Psoriasis: weight lost mattered more than fasting

Psoriasis is a chronic immune-mediated inflammatory skin disease, and it travels closely with metabolic dysregulation and excess body fat. That link has made diet an obvious adjunct to consider alongside standard treatment, on the reasoning that reducing energy intake could improve skin severity through weight loss, metabolic improvements, changes in gut microbiota and broader immune-metabolic effects. The awkward part is that several very different strategies all claim the same territory: continuous daily calorie restriction, intermittent fasting and ketogenic diets. This review set out to ask which of them actually shifts psoriasis severity, and by how much.

The authors designed a systematic review and meta-analysis comparing the therapeutic effectiveness of intermittent fasting, ketogenic diets and continuous caloric restriction for reducing psoriasis severity. The main clinical outcome was change in the Psoriasis Area and Severity Index, the standard scored measure of how much skin is affected and how badly. Quality of life was assessed using the Dermatology Life Quality Index, and metabolic scores were also collected. Psoriasis extent and outcome measures were recorded at baseline and then at the various follow-up timeframes used by the individual included studies, which differed from one another. Notably, the published abstract does not state how many trials or participants were pooled.

Psoriasis Area and Severity Index scores fell significantly in the ketogenic and continuous calorie-restriction cohorts, which recorded weight losses in the range of 10-25.6 kg. The intermittent fasting cohorts, by contrast, lost only 0-2 kg and did not show the same significant improvement in severity. No serious adverse effects were recorded with any of the three interventions. The authors were explicit that the comparison is indirect: there were no head-to-head studies, the included work was heterogeneous, and follow-up was limited, so the size of the advantage for the calorie-restriction and ketogenic approaches cannot be pinned down precisely.

The result sits comfortably with the long-recognised association between excess adiposity and psoriasis severity, and it adds a practical wrinkle: the approaches that produced large weight losses were also the ones linked to better skin scores, while the approach that produced almost no weight change was not. That pattern suggests the amount of energy deficit achieved may matter more than the particular eating schedule, but this review cannot separate the two. Open questions remain about whether ketogenic diets add anything beyond the weight loss they produce, whether intermittent fasting would perform differently if it delivered comparable weight loss, and what happens to skin severity over longer follow-up. Direct randomised comparisons are still missing.

If you have psoriasis and are weighing up diet as an add-on to your usual treatment, this is a reason to think that how much weight an approach actually shifts may matter more than which fashionable label it carries. Intermittent fasting, in the studies gathered here, barely moved body weight, and skin scores did not improve significantly alongside it. Reassuringly, none of the strategies was associated with serious adverse effects. This is weak, indirect evidence from a heterogeneous set of studies with short follow-up rather than a settled comparison, so it is a starting point for a conversation with your clinician, not a verdict on any one diet.